NASA’s JPL selects Planet Innovation to manufacture ventilator in Australia
9 June 2020 NASA’s Jet Propulsion Laboratory has selected Planet Innovation as the only Australian manufacturer of a new ventilator tailored for COVID-19 patients. PI is among 13 international companies and eight U.S. manufacturers selected from more than…
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
5 June 2020 • CSL appointed Trusted Manufacturer for University of Queensland’s “molecular clamp” enabled COVID-19 vaccine candidate • CEPI and CSL will share costs associated with the clinical development and manufacture of the vaccine candidate • A…
Monash University and oNKo-innate Announce Research Partnership
4 June 2020 An innovative research partnership has been established between Monash University and new Melbourne-based start up, oNKo-innate Pty Ltd. The unique partnership sees oNKo-innate, co-founded by Professor Nicholas Huntington and Dr Jai Rautela, being based at the Monash Biomedicine Discovery…
Muscle tech: Sleep apnea therapeutic showcased at global biotech event
4 June 2020 A world-first therapeutic for treating sleep apnea and a range of other weak muscle conditions will be unveiled this month at global biotech innovation event, BIO Digital. Developed by RMIT in collaboration with Snoretox Pty…
World First In 3D Printing Gives A Personal Touch To Keep The Blood Flowing
4 June 2020 Researchers from CSIRO, Australia’s national science agency, have made it possible to 3D print tailor-made stents, a critical biomedical device used to treat narrow or blocked arteries. The breakthrough, made in partnership with Wollongong-based Medical…
Australian Government invests in new medicines for COVID-19
2 June 2020 The Australian Government will invest $3M in Walter and Eliza Hall Institute research programs that are developing new classes of medicines for COVID-19. The funding from the Medical Research Future Fund (MRFF) will support…
Dimerix Drug in WHO COVID-19 Trial
4 June 2020 Global platform trial taps Australian drug for major global COVID-19 treatment study As the world mobilises to bring to bear the full scientific resources it can to fight the COVID-19 pandemic, an Australian biotech…
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
1 June 2020 AbbVie, a research-based global biopharmaceutical company, and Jacobio Pharmaceuticals, a clinical-stage pharmaceutical company, today announced a global, strategic collaboration to develop and commercialize SHP2 inhibitors, which target a key node in cancer and immune cells. SHP2 is…
Certara Broadens and Increases Regulatory Strength with Two Executive Hires
21 May 2020 Certara®, the global leader in model-informed drug development and regulatory science announced the appointments of Terrance (Terry) Ocheltree, Ph.D., R.Ph. as vice president of regulatory strategy and chemistry, manufacturing and controls (CMC) and Lynne Georgopoulos,…
Human insulin enhanced with cone snail ‘blue print’
2 June 2020 Diabetes treatments could be improved following the development of a dramatically modified form of human insulin, called ‘Mini-Ins’, that successfully mimics the ultra-fast-acting properties of cone snail venom insulin. Mini-Ins has demonstrated significant promise…
Noxopharm: ASCO 2020 Highlights NOX66 Potential in Late-Stage Cancer
1 June 2020 Highlights: NOX66 (Veyonda®) clinical data released to world-wide audience Anti-cancer responses (tumor size and pain responses) observed in approximately two-thirds of men with end-stage prostate cancer Abscopal responses in approximately one-quarter of men with end-stage…
Immutep Reports First Results from INSIGHT-004 Study
1 June 2020 First data from this collaboration study with Merck KGaA, Darmstadt, Germany, and Pfizer Inc and sponsor, IKF, presented at ASCO Encouraging early activity signals in a variety of cancer indications Overall, 33% of patients showed…
